| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $54.74B | -2.5% |
| Cost of Revenue | $20.01B | -8.9% |
| R&D Expense | $81.0M | +0.0% |
| SG&A Expense | $1.16B | +64.3% |
| Interest Expense | $783.0M | +0.4% |
| Pre-tax Income | $13.67B | -16.1% |
| Income Tax | $4.43B | -17.0% |
| Net Income | $9.24B | -15.6% |
| EPS (Basic) | $7.82 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.61B | -0.5% |
| Short-term Investments | $507.0M | -47.8% |
| Inventory | $1.81B | +29.4% |
| Current Assets | $15.65B | +9.2% |
| Total Assets | $122.78B | +28.0% |
| Current Liabilities | $12.12B | +21.2% |
| Long-term Debt | $23.29B | +30.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $20.12B | +0.8% |
| Investing Cash Flow | -$11.15B | +7.1% |
| Financing Cash Flow | -$8.84B | -2.0% |
| -13.9% |
| EPS (Diluted) | $7.81 | -13.8% |
| Total Liabilities |
| $57.98B |
| +24.3% |
| Stockholders' Equity | $64.80B | +31.5% |